Stockreport

Jupiter Neurosciences to Present at Emerging Growth Conference on April 2

Jupiter Neurosciences, Inc.  (JUNS) 
PDF JUPITER, FL, March 31, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company develo [Read more]